VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression

Ying Cao, Guangqi E, Enfeng Wang, Krishnendu Pal, Shamit K. Dutta, Dafna Bar-Sagi, Debabrata Mukhopadhyay

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

VEGF/vascular permeability factor (VEGF/VPF or VEGF-A) is a pivotal driver of cancer angiogenesis that is a central therapeutic target in the treatment of malignancy. However, little work has been devoted to investigating functions of VEGF that are independent of its proangiogenic activity. Here, we report that VEGF produced by tumor cells acts in an autocrine manner to promote cell growth through interaction with the VEGF receptor neuropilin-1 (NRP-1). Reducing VEGF expression by tumor cells induced a differentiated phenotype in vitro and inhibited tumor forming capacity in vivo, independent of effects on angiogenesis. Autocrine activation of tumor cell growth was dependent on signaling through NRP-1, and Ras was determined to be a critical effector signaling molecule downstream of NRP-1. Our findings define a novel function for VEGF in dedifferentiation of tumor cells expanding its role in cancer beyond its known proangiogenic function.

Original languageEnglish (US)
Pages (from-to)3912-3918
Number of pages7
JournalCancer Research
Volume72
Issue number16
DOIs
StatePublished - Aug 15 2012

Fingerprint

Vascular Endothelial Growth Factor A
Neuropilin-1
Neoplasms
Cell Dedifferentiation
Vascular Endothelial Growth Factor Receptor
Growth
Phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. / Cao, Ying; E, Guangqi; Wang, Enfeng; Pal, Krishnendu; Dutta, Shamit K.; Bar-Sagi, Dafna; Mukhopadhyay, Debabrata.

In: Cancer Research, Vol. 72, No. 16, 15.08.2012, p. 3912-3918.

Research output: Contribution to journalArticle

Cao, Ying ; E, Guangqi ; Wang, Enfeng ; Pal, Krishnendu ; Dutta, Shamit K. ; Bar-Sagi, Dafna ; Mukhopadhyay, Debabrata. / VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. In: Cancer Research. 2012 ; Vol. 72, No. 16. pp. 3912-3918.
@article{cb3a80902bb346caa5fb9d4a654b93ce,
title = "VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression",
abstract = "VEGF/vascular permeability factor (VEGF/VPF or VEGF-A) is a pivotal driver of cancer angiogenesis that is a central therapeutic target in the treatment of malignancy. However, little work has been devoted to investigating functions of VEGF that are independent of its proangiogenic activity. Here, we report that VEGF produced by tumor cells acts in an autocrine manner to promote cell growth through interaction with the VEGF receptor neuropilin-1 (NRP-1). Reducing VEGF expression by tumor cells induced a differentiated phenotype in vitro and inhibited tumor forming capacity in vivo, independent of effects on angiogenesis. Autocrine activation of tumor cell growth was dependent on signaling through NRP-1, and Ras was determined to be a critical effector signaling molecule downstream of NRP-1. Our findings define a novel function for VEGF in dedifferentiation of tumor cells expanding its role in cancer beyond its known proangiogenic function.",
author = "Ying Cao and Guangqi E and Enfeng Wang and Krishnendu Pal and Dutta, {Shamit K.} and Dafna Bar-Sagi and Debabrata Mukhopadhyay",
year = "2012",
month = "8",
day = "15",
doi = "10.1158/0008-5472.CAN-11-4058",
language = "English (US)",
volume = "72",
pages = "3912--3918",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression

AU - Cao, Ying

AU - E, Guangqi

AU - Wang, Enfeng

AU - Pal, Krishnendu

AU - Dutta, Shamit K.

AU - Bar-Sagi, Dafna

AU - Mukhopadhyay, Debabrata

PY - 2012/8/15

Y1 - 2012/8/15

N2 - VEGF/vascular permeability factor (VEGF/VPF or VEGF-A) is a pivotal driver of cancer angiogenesis that is a central therapeutic target in the treatment of malignancy. However, little work has been devoted to investigating functions of VEGF that are independent of its proangiogenic activity. Here, we report that VEGF produced by tumor cells acts in an autocrine manner to promote cell growth through interaction with the VEGF receptor neuropilin-1 (NRP-1). Reducing VEGF expression by tumor cells induced a differentiated phenotype in vitro and inhibited tumor forming capacity in vivo, independent of effects on angiogenesis. Autocrine activation of tumor cell growth was dependent on signaling through NRP-1, and Ras was determined to be a critical effector signaling molecule downstream of NRP-1. Our findings define a novel function for VEGF in dedifferentiation of tumor cells expanding its role in cancer beyond its known proangiogenic function.

AB - VEGF/vascular permeability factor (VEGF/VPF or VEGF-A) is a pivotal driver of cancer angiogenesis that is a central therapeutic target in the treatment of malignancy. However, little work has been devoted to investigating functions of VEGF that are independent of its proangiogenic activity. Here, we report that VEGF produced by tumor cells acts in an autocrine manner to promote cell growth through interaction with the VEGF receptor neuropilin-1 (NRP-1). Reducing VEGF expression by tumor cells induced a differentiated phenotype in vitro and inhibited tumor forming capacity in vivo, independent of effects on angiogenesis. Autocrine activation of tumor cell growth was dependent on signaling through NRP-1, and Ras was determined to be a critical effector signaling molecule downstream of NRP-1. Our findings define a novel function for VEGF in dedifferentiation of tumor cells expanding its role in cancer beyond its known proangiogenic function.

UR - http://www.scopus.com/inward/record.url?scp=84865141645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865141645&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-4058

DO - 10.1158/0008-5472.CAN-11-4058

M3 - Article

C2 - 22693250

AN - SCOPUS:84865141645

VL - 72

SP - 3912

EP - 3918

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -